Biofilm formation by staphylococci in health-related environments and recent reports on their control using natural compounds

Critical Reviews in Microbiology
Yi Yi YongWee Sim Choo

Abstract

Staphylococci are Gram-positive bacteria that are ubiquitous in the environment and able to form biofilms on a range of surfaces. They have been associated with a range of human health issues such as medical device-related infection, localized skin infection, or direct infection caused by toxin production. The extracellular material produced by these bacteria resists antibiotics and host defence mechanism which complicates the treatment process. The commonly reported Staphylococcus species are Staphylococcus aureus and S. epidermidis as they inhabit human bodies. However, the emergence of other staphylococci, such as S. haemolyticus, S. lugdunensis, S. saprophyticus, S. capitis, S. saccharolyticus, S. warneri, S. cohnii, and S. hominis, is also of concern and they have been associated with biofilm formation. This review critically assesses recent cases on the biofilm formation by S. aureus, S. epidermidis, and other staphylococci reported in health-related environments. The control of biofilm formation by staphylococci using natural compounds is specifically discussed as they represent potential anti-biofilm agents which may reduce the burden of antibiotic resistance.

References

Dec 1, 1990·Journal of Clinical Microbiology·T U WestblomA H Schindzielorz
Aug 1, 1995·Epidemiology and Infection·N H EriksenK Jensen
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·W M DunneS L Kaplan
Apr 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S KrishnanT Roat
Mar 19, 1999·Emerging Infectious Diseases·R J RubinA Moiduddin
May 13, 1999·International Journal of Systematic Bacteriology·T TakahashiN Kikuchi
Mar 29, 2000·Journal of Applied Microbiology·W L CochranP S Stewart
Oct 6, 2000·Annual Review of Microbiology·G O'TooleR Kolter
Mar 21, 2001·Antimicrobial Agents and Chemotherapy·K Lewis
Apr 9, 2001·Journal of Bacteriology·C CucarellaJ R Penadés
Apr 11, 2001·Emerging Infectious Diseases·R P Wenzel, M B Edmond
May 12, 2001·FEMS Microbiology Reviews·O McAuliffeC Hill
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Zhilan Zheng, Philip S Stewart
Jun 29, 2002·Journal of Clinical Microbiology·Wil C Van Der ZwetChristina M J E Vandenbroucke-Grauls
Aug 27, 2002·Emerging Infectious Diseases·Rodney M Donlan
Nov 1, 2002·The Lancet Infectious Diseases·Christof von EiffChristine Heilmann
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Scott WalshJames Mond
Apr 12, 2003·Journal of Clinical Microbiology·N van der Mee-MarquetR Quentin
May 23, 2003·Antimicrobial Agents and Chemotherapy·Andrea GiacomettiGiorgio Dell'Acqua
Jun 24, 2003·Infection and Immunity·Karen E BeenkenMark S Smeltzer
Aug 23, 2003·The Journal of Infectious Diseases·Cuong VuongMichael Otto
May 4, 2004·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·R GhiselliV Saba
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Anjali ShahScott Walsh
Jun 25, 2004·The Journal of Infectious Diseases·Giorgio Dell'AcquaNaomi Balaban
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Niels Høiby
Nov 24, 2004·FEMS Microbiology Letters·Martin NilssonLars Frykberg
Feb 3, 2005·Biological & Pharmaceutical Bulletin·Mitsuyoshi MatsuoTakao Kaneko
Mar 1, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Raul RazCalvin M Kunin
Mar 8, 2005·Journal of Clinical Microbiology·Arjanne van GriethuysenJan Kluytmans
Sep 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Makoto KurodaToshiko Ohta
Dec 13, 2005·Current Opinion in Immunology·Kelly L Brown, Robert E W Hancock
Dec 15, 2005·The International Journal of Artificial Organs·J W CostertonC R Arciola

❮ Previous
Next ❯

Citations

Aug 15, 2020·Expert Review of Anti-infective Therapy·Mehran AlaviEsmaiel Jabbari
Dec 5, 2019·Antibiotics·Reuven RasoolyEmmanouil Apostolidis
Nov 17, 2020·Frontiers in Microbiology·Rojita MishraJunaid Khan
Aug 1, 2019·Current Drug Discovery Technologies·Neha Jain, Abdulkhalik Mansuri
Mar 3, 2021·International Journal of Environmental Health Research·Somia SaadiMohammed Bakkali
Feb 13, 2021·Genome Biology and Evolution·Anna LavecchiaAntonio Placido
Aug 21, 2021·Future Microbiology·Anjali WarrierThokur Sreepathy Murali

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.